HUSSMAN STRATEGIC ADVISORS, INC. Intra-Cellular Therapies, Inc. Transaction History

HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:

$721,000
portfolio value

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 15.5K shares 721K $46.53 15.5K
Q3 2021 share Decrease -100.00% -31K shares -1.26M $37.28 0
Q2 2021 share Increase 0.00% 31K shares 1.26M $40.82 31K